Bortezomib

VELCADE®

Overview

Bortezomib is used to treat multiple myeloma and mantle cell lymphoma. It is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Bortezomib is given as an injection under the skin (subcutaneously) or injected into a vein through an IV.

SparkCures ID 1
Developed By Takeda Oncology
Brand Name Velcade®
Generic Name Bortezomib
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.